Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Pardubice – page 16

574 clinical trials in Pardubice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Pardubice at a glance
574
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

574 trials in Pardubice

Open in trial search

Pneumonia

Recruiting

Study of Trimodulin for Adults Hospitalized with Severe Community-Acquired Pneumonia

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Biotest GmbH & Co. KGaA

Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)

Study on the Effects of Azetukalner in Patients with Focal-Onset Seizures

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Xenon Pharmaceuticals Inc.

Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study on the Effectiveness of Eltrombopag in Combination with Other Drugs for Patients with Immune Thrombocytopenia

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Avatrombopag
  • Sponsor:Fakultni Nemocnice Hradec Kralove

Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:CEEGOG z.s.

Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BMS-986515
  • Sponsor:Celgene Corp.

Study on Long-Term Safety of Secukinumab for Patients with Psoriatic Arthritis, Ankylosing Spondylitis, and Severe Chronic Plaque Psoriasis

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Crohn's disease

Recruiting

Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ABBV-8736
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Type 2 diabetes mellitus+1

Not yet recruiting

Efficacy and Safety of Petrelintide in Adults with Overweight or Obesity and Type 2 Diabetes: A Phase III Randomized Placebo‑Controlled Trial

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide
  • Sponsor:F. Hoffmann-La Roche AG

Dermatitis atopic

Not yet recruiting

Efficacy and Safety of Rezpegaldesleukin (NKTR-358) in Patients Aged ≥12 Years with Moderate-to-Severe Atopic Dermatitis

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rezpegaldesleukin
  • Sponsor:Nektar Therapeutics

Petosemtamab versus cetuximab plus drug combination as first‑line treatment for adults with metastatic left‑sided colorectal cancer

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Genmab A/S

Other cities in Czechia

The busiest research cities in the country

All 150 cities in Czechia

Clinical research in Pardubice

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical trials focusing on vaccine development for preventable diseases, including studies of new chickenpox vaccines and advanced meningococcal vaccines for infants and children.

  • Varicella immunization
  • Meningococcal disease prevention
  • Pediatric vaccine safety

Research emphasizes immune response monitoring and safety assessment in young populations.

02 Autoimmune Conditions

Innovative research targeting various autoimmune disorders, with studies evaluating new treatments for psoriatic arthritis and multiple sclerosis.

  • Plaque psoriasis treatments
  • MS therapy advancement
  • Immune system modulation

Trials focus on developing targeted therapies for chronic inflammatory conditions.

03 Neurological Disorders

Studies investigating new therapeutic approaches for Parkinson's Disease and other neurological conditions, with emphasis on improving patient outcomes.

  • Movement disorders
  • Neurodegenerative diseases
  • Symptom management

Research aims to enhance treatment options and quality of life for patients.

04 Oncology Research

Advanced clinical trials focusing on prostate cancer treatment, particularly addressing metastatic castration-resistant cases.

  • Targeted cancer therapies
  • Hormone-resistant cancers
  • Combination treatments

Studies emphasize novel therapeutic approaches for advanced-stage cancers.

05 Musculoskeletal Conditions

Research investigating treatments for osteoarthritis and joint disorders, including innovative therapies for knee-specific conditions.

  • Pain management
  • Joint function improvement
  • Inflammatory conditions

Focus on developing both systemic and topical treatments for joint diseases.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.